{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T23:54:55Z","timestamp":1780098895727,"version":"3.54.0"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T00:00:00Z","timestamp":1621468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Blocking interferon-function by therapeutic intervention of the JAK-STAT-axis is a novel promising treatment option for inflammatory bowel disease (IBD). Although JAK inhibitors have proven efficacy in patients with active ulcerative colitis (UC), they failed to induce clinical remission in patients with Crohn's disease (CD). This finding strongly implicates a differential contribution of JAK signaling in both entities. Here, we dissected the contribution of different STAT members downstream of JAK to inflammation and barrier dysfunction in a mouse model of Crohn's disease like ileitis and colitis (<jats:italic>Casp8<\/jats:italic><jats:sup>\u0394<jats:italic>IEC<\/jats:italic><\/jats:sup> mice). Deletion of STAT1 in <jats:italic>Casp8<\/jats:italic><jats:sup>\u0394<jats:italic>IEC<\/jats:italic><\/jats:sup> mice was associated with reduced cell death and a partial rescue of Paneth cell function in the small intestine. Likewise, organoids derived from the small intestine of these mice were less sensitive to cell death triggered by IBD-key cytokines such as TNF\u03b1 or IFNs. Further functional <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic> analyses revealed the impairment of MLKL-mediated necrosis as a result of deficient STAT1 function, which was in turn associated with improved cell survival. However, a decrease in inflammatory cell death was still associated with mild inflammation in the small intestine. The impact of STAT1 signaling on gastrointestinal inflammation dependent on the localization of inflammation, as STAT1 is essential for intestinal epithelial cell death regulation in the small intestine, whereas it is not the key factor for intestinal epithelial cell death in the context of colitis. Of note, additional deletion of STAT2 was not sufficient to restore Paneth cell function but strongly ameliorated ileitis. In summary, we provide here compelling molecular evidence that STAT1 and STAT2, both contribute to intestinal homeostasis, but have non-redundant functions. Our results further demonstrate that STATs individually affect the distinct pathophysiology of inflammation in the ileum and colon, respectively, which might explain the diverse outcome of JAK inhibitors on inflammatory bowel diseases.<\/jats:p>","DOI":"10.3389\/fmed.2021.644244","type":"journal-article","created":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T05:30:40Z","timestamp":1621488640000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["An IFN-STAT Axis Augments Tissue Damage and Inflammation in a Mouse Model of Crohn's Disease"],"prefix":"10.3389","volume":"8","author":[{"given":"Iris","family":"Stolzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Dressel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mircea T.","family":"Chiriac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus F.","family":"Neurath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"G\u00fcnther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,5,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"9361802","DOI":"10.1155\/2017\/9361802","article-title":"Getting \u201cInside\u201d Type I IFNs: Type I IFNs in intracellular bacterial infections","volume":"2017","author":"Snyder","year":"2017","journal-title":"J Immunol Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/imr.12195","article-title":"The role of type I interferons in intestinal infection, homeostasis, and inflammation","volume":"260","author":"Cho","year":"2014","journal-title":"Immunol Rev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.chom.2016.05.016","article-title":"The roles of type i interferon in bacterial infection","volume":"19","author":"Boxx","year":"2016","journal-title":"Cell Host Microbe."},{"key":"B4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3389\/fimmu.2017.00029","article-title":"Canonical and non-canonical aspects of JAK-STAT signaling: lessons from interferons for cytokine responses","volume":"8","author":"Majoros","year":"2017","journal-title":"Front Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.3390\/ijms20061445","article-title":"Differential regulation of Type I and Type III interferon signaling","volume":"20","author":"Stanifer","year":"2019","journal-title":"Int J Mol Sci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1038\/s41590-019-0466-2","article-title":"Interferon target-gene expression and epigenomic signatures in health and disease","volume":"20","author":"Barrat","year":"2019","journal-title":"Nat Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nri3661","article-title":"Cytokines in inflammatory bowel disease","volume":"14","author":"Neurath","year":"2014","journal-title":"Nat Rev Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/j.1365-2249.2006.03214.x","article-title":"Interferon-gamma is causatively involved in experimental inflammatory bowel disease in mice","volume":"146","author":"Ito","year":"2006","journal-title":"Clin Exp Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1006\/mvre.2000.2288","article-title":"Interferon-gamma and interleukin-10 reciprocally regulate endothelial junction integrity and barrier function","volume":"61","author":"Oshima","year":"2001","journal-title":"Microvasc Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.cyto.2015.10.008","article-title":"Chemokine and cytokine levels in inflammatory bowel disease patients","volume":"77","author":"Singh","year":"2016","journal-title":"Cytokine."},{"key":"B11","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1089\/jir.2010.0012","article-title":"Involvement of interferon-gamma in bowel disease pathogenesis by nitric oxide pathway: a study in algerian patients","volume":"30","author":"Rafa","year":"2010","journal-title":"J Interferon Cytokine Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1089\/jir.2011.0101","article-title":"Interferons in autoimmune and inflammatory diseases: regulation and roles","volume":"31","author":"Choubey","year":"2011","journal-title":"J Interferon Cytokine Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1053\/j.gastro.2019.07.031","article-title":"Interferon lambda promotes paneth cell death via STAT1 signaling in mice and is increased in inflamed ileal tissues of patients with crohn's disease","volume":"157","author":"Gunther","year":"2019","journal-title":"Gastroenterology."},{"key":"B14","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1053\/j.gastro.2017.03.015","article-title":"Activation of epithelial signal transducer and activator of transcription 1 by interleukin 28 controls mucosal healing in mice with colitis and is increased in mucosa of patients with inflammatory bowel disease","volume":"153","author":"Chiriac","year":"2017","journal-title":"Gastroenterology."},{"key":"B15","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1053\/j.gastro.2018.09.041","article-title":"Intestinal inflammation and dysregulated immunity in patients with inherited caspase-8 deficiency","volume":"156","author":"Lehle","year":"2019","journal-title":"Gastroenterology."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.3324\/haematol.2018.201673","article-title":"Lymphoproliferation, immunodeficiency and early-onset inflammatory bowel disease associated with a novel mutation in Caspase 8","volume":"104","author":"Kanderova","year":"2019","journal-title":"Haematologica."},{"key":"B17","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nature10400","article-title":"Caspase-8 regulates TNF-alpha-induced epithelial necroptosis and terminal ileitis","volume":"477","author":"Gunther","year":"2011","journal-title":"Nature."},{"key":"B18","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1093\/ibd\/izz142","article-title":"Environmental microbial factors determine the pattern of inflammatory lesions in a murine model of crohn's disease-like inflammation","volume":"26","author":"Stolzer","year":"2020","journal-title":"Inflamm Bowel Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.immuni.2020.04.002","article-title":"FADD and caspase-8 regulate gut homeostasis and inflammation by controlling MLKL- and GSDMD-mediated death of intestinal epithelial cells","volume":"52","author":"Schwarzer","year":"2020","journal-title":"Immunity"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1053\/j.gastro.2013.08.059","article-title":"Cellular FLICE-like inhibitory protein secures intestinal epithelial cell survival and immune homeostasis by regulating caspase-8","volume":"145","author":"Wittkopf","year":"2013","journal-title":"Gastroenterology."},{"key":"B21","doi-asserted-by":"publisher","first-page":"125","DOI":"10.20524\/aog.2020.0457","article-title":"Inflammatory bowel disease pathobiology: the role of the interferon signature","volume":"33","author":"Andreou","year":"2020","journal-title":"Ann Gastroenterol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1056\/NEJMoa1606910","article-title":"Tofacitinib as induction and maintenance therapy for ulcerative colitis","volume":"376","author":"Sandborn","year":"2017","journal-title":"N Engl J Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"572","DOI":"10.20524\/aog.2018.0276","article-title":"Tofacitinib for induction of remission in ulcerative colitis: systematic review and meta-analysis","volume":"31","author":"Paschos","year":"2018","journal-title":"Ann Gastroenterol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1136\/gutjnl-2016-312735","article-title":"Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials","volume":"66","author":"Panes","year":"2017","journal-title":"Gut."},{"key":"B25","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/apt.15072","article-title":"Long-term safety and tolerability of oral tofacitinib in patients with Crohn's disease: results from a phase 2, open-label, 48-week extension study","volume":"49","author":"Panes","year":"2019","journal-title":"Aliment Pharmacol Ther."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/j.cgh.2014.01.029","article-title":"A phase 2 study of tofacitinib, an oral Janus kinase inhibitor, in patients with Crohn's disease","volume":"12","author":"Sandborn","year":"2014","journal-title":"Clin Gastroenterol Hepatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/S0140-6736(16)32537-5","article-title":"Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial","volume":"389","author":"Vermeire","year":"2017","journal-title":"Lancet."},{"key":"B28","doi-asserted-by":"publisher","first-page":"4055","DOI":"10.3748\/wjg.v26.i28.4055","article-title":"Differential regulation of JAK\/STAT-signaling in patients with ulcerative colitis and Crohn's disease","volume":"26","author":"Cordes","year":"2020","journal-title":"World J Gastroenterol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S0092-8674(00)81289-1","article-title":"Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease","volume":"84","author":"Durbin","year":"1996","journal-title":"Cell."},{"key":"B30","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S1074-7613(00)00077-7","article-title":"Immune response in Stat2 knockout mice","volume":"13","author":"Park","year":"2000","journal-title":"Immunity."},{"key":"B31","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1136\/gut.2004.061283","article-title":"In vivo imaging of colitis and colon cancer development in mice using high resolution chromoendoscopy","volume":"54","author":"Becker","year":"2005","journal-title":"Gut."},{"key":"B32","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/nature07935.","article-title":"Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche","volume":"459","author":"Sato","year":"2009","journal-title":"Nature"},{"key":"B33","doi-asserted-by":"publisher","first-page":"4346","DOI":"10.1172\/JCI87545","article-title":"The pseudokinase MLKL mediates programmed hepatocellular necrosis independently of RIPK3 during hepatitis","volume":"126","author":"Gunther","year":"2016","journal-title":"J Clin Invest."},{"key":"B34","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1136\/gutjnl-2014-307226","article-title":"Caspase-8 controls the gut response to microbial challenges by Tnf-alpha-dependent and independent pathways","volume":"64","author":"Gunther","year":"2015","journal-title":"Gut."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.3748\/wjg.v20.i5.1165","article-title":"Intestinal barrier in inflammatory bowel disease","volume":"20","author":"Antoni","year":"2014","journal-title":"World J Gastroenterol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2868","DOI":"10.1084\/jem.20171029","article-title":"ATG16L1 orchestrates interleukin-22 signaling in the intestinal epithelium via cGAS-STING","volume":"215","author":"Aden","year":"2018","journal-title":"J Exp Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.chom.2012.01.016","article-title":"DAI\/ZBP1\/DLM-1 complexes with RIP3 to mediate virus-induced programmed necrosis that is targeted by murine cytomegalovirus vIRA","volume":"11","author":"Upton","year":"2012","journal-title":"Cell Host Microbe."},{"key":"B38","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41423-019-0237-x","article-title":"ZBP1 mediates interferon-induced necroptosis","volume":"17","author":"Yang","year":"2020","journal-title":"Cell Mol Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/s41586-020-2127-x","article-title":"Gut stem cell necroptosis by genome instability triggers bowel inflammation","volume":"580","author":"Wang","year":"2020","journal-title":"Nature."},{"key":"B40","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1572-0241.2005.40615.x","article-title":"Activation pattern of signal transducers and activators of transcription (STAT) factors in inflammatory bowel diseases","volume":"100","author":"Mudter","year":"2005","journal-title":"Am J Gastroenterol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.644244\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T17:14:48Z","timestamp":1622567688000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.644244\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,20]]},"references-count":40,"alternative-id":["10.3389\/fmed.2021.644244"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.644244","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,20]]},"article-number":"644244"}}